Prosecution Insights
Last updated: May 04, 2026
Application No. 17/681,969

DISPLAY FOR DUAL-MODE MEDICAL DEVICE

Non-Final OA §112
Filed
Feb 28, 2022
Priority
Nov 30, 2009 — provisional 61/265,309 +4 more
Examiner
JOHNSON, NICOLE F
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Zoll Medical Corporation
OA Round
5 (Non-Final)
87%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allowance Rate
1184 granted / 1355 resolved
+17.4% vs TC avg
Moderate +7% lift
Without
With
+7.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
53 currently pending
Career history
1408
Total Applications
across all art units

Statute-Specific Performance

§101
9.0%
-31.0% vs TC avg
§103
34.4%
-5.6% vs TC avg
§102
33.6%
-6.4% vs TC avg
§112
9.7%
-30.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1355 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on November 12, 2025 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 17-22 & 24-37 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. In regards to independent claim 17, the claim contains limitations, such as “…removing from view on the display the one or more first indicators that provide graphics indicating electrode application to a patient…” that are not explicitly supported by the written description. The specification provides support for the display of the “one or more first indicators,” but there in nothing providing evidence for the claimed act of “removing” said indicators from view. The limitation(s) is not described in the specification in such a way as to reasonably convey to one skilled in the relevant art the claimed removal of the one or more first indicators. Response to Arguments The examiner acknowledges the interview conducted and thanks the applicant for presenting claim amendments that would promote compact prosecution. Applicant’s arguments, filed November 2nd, 2025, with respect to the 35 U.S.C 103 rejections of claims 17-18, 21, 24-31, 34-35 & 36 have been fully considered and are persuasive and have been withdrawn. The examiner notes that the claims are not rejected based on any prior art statutes. However, the pending claims stand rejected based on a 35 U.S.C 112, first paragraph, i.e. new matter, rejection. Please see the above action. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICOLE F JOHNSON whose telephone number is (571)270-5040. The examiner can normally be reached Monday-Friday 8:00am-5:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICOLE F JOHNSON/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Show 20 earlier events
Nov 05, 2025
Response after Non-Final Action
Nov 12, 2025
Request for Continued Examination
Nov 19, 2025
Response after Non-Final Action
Nov 19, 2025
Non-Final Rejection — §112
Mar 17, 2026
Interview Requested
Mar 23, 2026
Applicant Interview (Telephonic)
Mar 23, 2026
Examiner Interview Summary
Mar 24, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12611139
METHODS, SYSTEMS, AND DEVICES FOR DETECTING SLEEP AND APNEA EVENTS
2y 5m to grant Granted Apr 28, 2026
Patent 12599328
METHOD TO DETECT NOISE IN A WEARABLE CARDIOVERTER DEFIBRILLATOR
2y 5m to grant Granted Apr 14, 2026
Patent 12594420
TETHER ASSEMBLIES FOR MEDICAL DEVICE DELIVERY SYSTEMS
2y 9m to grant Granted Apr 07, 2026
Patent 12588858
WEIGHTING PROJECTED ELECTROPHYSIOLOGICAL WAVE VELOCITY WITH SIGMOID CURVE
4y 6m to grant Granted Mar 31, 2026
Patent 12575803
THERAPEUTIC DEVICE INCLUDING ACOUSTIC SENSOR
2y 4m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
87%
Grant Probability
95%
With Interview (+7.2%)
2y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1355 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month